UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Leukemia, 2011-07, Vol.25 (7), p.1147-1152

2011

Volltextzugriff (PDF)

Targeting MYC in multiple myeloma

Leukemia, 2018-06, Vol.32 (6), p.1295-1306

2018

Volltextzugriff (PDF)

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Leukemia, 2010-05, Vol.24 (5), p.1094-1096

2010

Volltextzugriff (PDF)

RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage

Cell death & disease, 2014-08, Vol.5 (8), p.e1384-e1384

2014

Volltextzugriff (PDF)

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Leukemia, 2006-06, Vol.20 (6), p.965-970

2006

Volltextzugriff (PDF)

Structural geology of the Cadillac Group along the Malartic segment of the Larder Lake Cadillac deformation zone, Quebec, and implications for gold mineralization

Canadian journal of earth sciences, 2022-09, Vol.59 (9), p.540-565

2022

Volltextzugriff (PDF)

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.539-543

2017

Volltextzugriff (PDF)

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

Leukemia, 2017-03, Vol.31 (3), p.555-564

2017

Volltextzugriff (PDF)

GATA2 gene mutations: 3 cases

La revue de medecine interne, 2022-11, Vol.43 (11), p.677-682

2022

Volltextzugriff (PDF)

Thoracic air bubbles of unusual cause

La revue de medecine interne, 2020-10, Vol.41 (10), p.714-715

2020

Volltextzugriff (PDF)

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

Leukemia, 2016-06, Vol.30 (6), p.1416-1418

2016

Volltextzugriff (PDF)

GILZ inhibits the mTORC2 AKT pathway in BCR-ABL cells

Oncogene, 2012-03, Vol.31 (11), p.1419-1430

2012

Volltextzugriff (PDF)

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2472-2479

2002

Volltextzugriff (PDF)

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

Leukemia, 2011-07, Vol.25 (7), p.1207-1209

2011

Volltextzugriff (PDF)

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MULTIPLE MYELOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.745-746

2022

Volltextzugriff (PDF)

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Leukemia, 2006-01, Vol.20 (1), p.35-41

2006

Volltextzugriff (PDF)

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes

Current research in translational medicine, 2017-04, Vol.65 (2), p.77-81

2017

Volltextzugriff (PDF)

P1257: MOLECULAR CHARACTERIZATION AND CLONAL EVOLUTION OF MYCOSIS FUNGOIDES

HemaSphere, 2022-06, Vol.6 (Suppl), p.1142-1143

2022

Volltextzugriff (PDF)

BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism

Leukemia, 2008-04, Vol.22 (4), p.791-799

2008

Volltextzugriff (PDF)

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies

European journal of cancer (1990), 2014-11, Vol.50, p.196-196

2014

Volltextzugriff (PDF)

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

Leukemia, 2007-03, Vol.21 (3), p.453-461

2007

Volltextzugriff (PDF)

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

Leukemia, 2006-11, Vol.20 (11), p.2067-2070

2006

Volltextzugriff (PDF)

PO-264 Mitochondrial metabolism: a key factor of myeloid leukemic cell response upon exposure to tyrosine kinase inhibitors

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A123-A124

2018

Volltextzugriff (PDF)

Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

Leukemia, 2007-11, Vol.21 (11), p.2376-2377

2007

Volltextzugriff (PDF)

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics

Leukemia, 2005-05, Vol.19 (5), p.792-798

2005

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(279)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(213)
Life Sciences & Biomedicine
(157)
Humans
(133)
Male
(77)
Female
(74)
Biological And Medical Sciences
(66)
Middle Aged
(62)
Hematology
(61)
Adult
(53)
Aged
(53)
Medical Sciences
(50)
Oncology
(46)
Physical Sciences
(37)
Hematologic And Hematopoietic Diseases
(26)
Aged, 80 And Over
(25)
Animals
(25)
Adolescent
(23)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)
Prognosis
(23)
Leukemia
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Targeting MYC in multiple myeloma

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Structural geology of the Cadillac Group along the Malartic segment of the Larder Lake Cadillac deformation zone, Quebec, and implications for gold mineralization

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

GATA2 gene mutations: 3 cases

Thoracic air bubbles of unusual cause

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

GILZ inhibits the mTORC2 AKT pathway in BCR-ABL cells

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MULTIPLE MYELOMA

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes

P1257: MOLECULAR CHARACTERIZATION AND CLONAL EVOLUTION OF MYCOSIS FUNGOIDES

BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

PO-264 Mitochondrial metabolism: a key factor of myeloid leukemic cell response upon exposure to tyrosine kinase inhibitors

Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics

Suchergebnisse filtern